CalciMedica
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of CalciMedica generated cash of -$25,730,000, which is less than the previous year. Cash used in financing activities reached the amount of $20,900,000 last year. Net change in cash is therefore $4,054,000.
Cash Flow
| 2018 | -28.21M | -1.46M | 42.01M |
|---|---|---|---|
| 2019 | -31.21M | -20.62M | 54.87M |
| 2020 | -32.06M | -42.56M | 92.17M |
| 2021 | -31.5M | 10.75M | 695K |
| 2022 | -22.87M | 26.95M | -139K |
| 2023 | -25.73M | 8.88M | 20.9M |
CALC Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 1.47M | 13.36M | 33.41M | 15.87M | 12.83M | 492K |
Operating activities | ||||||
Net income | -34.35M | -35.60M | -35.82M | -27.53M | -37.03M | -28.37M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 58K | 338K | 519K | 395K | 303K | 175K |
Stock-based compensation expense | 12.03M | 1.80M | 5.37M | 1.78M | 738K | 0 |
| Deferred income tax benefit | 12.03M | 1.80M | 5.37M | 1.78M | 738K | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -1.42M | 1.30M | -2.05M | -1.46M | 1.40M | 1.37M |
Cash generated by operating activities | -25.73M | -22.87M | -31.5M | -32.06M | -31.21M | -28.21M |
Investing activities | ||||||
Purchases Of Investments | -6.11M | -35.56M | -94.57M | -61.63M | -22.51M | 0 |
Investments In Property Plant And Equipment | -78K | -2.25M | -488K | -1.02M | -605K | -1.46M |
Acquisitions Net | 0 | 1.94M | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 8.88M | 26.95M | 10.75M | -42.56M | -20.62M | -1.46M |
Financing activities | ||||||
Common Stock Issued | 25.44M | 18K | 0 | 96.25M | 54.91M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | -45K | 0 |
Repayments of term debt | 0 | 8.45M | 0 | 0 | 0 | 0 |
Cash used in financing activities | 20.9M | -139K | 695K | 92.17M | 54.87M | 42.01M |
Net Change In Cash | 4.05M | 3.94M | -20.05M | 17.54M | 3.03M | 12.34M |
Cash at end of period | 5.53M | 17.30M | 13.36M | 33.41M | 15.87M | 12.83M |
| Data source |